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Background: We have shown that levels of circulating progenitor cells (PCs) predict future outcomes in patients with CAD. SDF-1α is a biomarker 
responsible for homing of PCs to ischemic tissues. We investigated the relationship between circulating levels of SDF1α and PCs and whether they 
enhance prediction of outcomes.
methods: 479 patients (age: 63±13 yrs.) undergoing coronary angiography were followed for mean 1.1 yrs. for incident cardiovascular death or 
myocardial infarction (MI). Baseline levels of plasma SDF-1α were measured using ELISA (R&D systems). Flow cytometry was used to enumerate 
CD34+/CD133+ cells in CD45med mononuclear cells. Cox regression was used to determine predictors of outcome.
results: Death/MI occurred in 7.5% (n=36). SDF- 1α level did not correlate with CD34+/CD133+ cells (p=0.25). Both high SDF-1α level (>2679 
ng/ml) and low CD34+/CD133+ levels (< 0.478 cells/µl) predicted risk of death/MI independent of other risk factors (HR: 3.4, p=0.005 and HR: 
2.5, p=0.02, respectively). A composite risk score of SDF-1α and PC levels predicted risk of death/MI; thus, compared to those with low SDF-1α/
high PCs, the hazard ratio was 8.5 (p=0.001) and 3.4 (p=0.04) for those with high SDF-1 α/low PCs and high SDF-1α/high PCs, respectively. The 
addition of the score to a model with traditional risk factors significantly improved discrimination (AUC: 0.70-0.78, p=0.03).
conclusion: A composite risk score of SDF-1α and PC levels significantly predicts risk of major outcomes in patients with CAD.
 
